These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease. Jenss H; Becker EW; Weber P Am J Gastroenterol; 1990 Mar; 85(3):332-3. PubMed ID: 2309693 [No Abstract] [Full Text] [Related]
4. [Current salazosulfapyridine derivatives in the treatment of Crohn's disease]. Belaiche J; Delwaide J; Louis E; Gast P Rev Med Liege; 1991 Jan; 46(1):16-22. PubMed ID: 2011676 [No Abstract] [Full Text] [Related]
5. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis. Messori A; Brignola C; Trallori G; Rampazzo R; Bardazzi G; Belloli C; d'Albasio G; De Simone G; Martini N Am J Gastroenterol; 1994 May; 89(5):692-8. PubMed ID: 8172139 [TBL] [Abstract][Full Text] [Related]
6. Acute pancreatitis in Crohn's disease due to 5-ASA therapy. Radke M; Bartolomaeus G; Müller M; Richter I J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):337-9. PubMed ID: 8492268 [No Abstract] [Full Text] [Related]
7. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease]. García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266 [TBL] [Abstract][Full Text] [Related]
8. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group. Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827 [TBL] [Abstract][Full Text] [Related]
9. [Pericardial effusion during the therapy of Crohn's disease with 5-aminosalicylic acid]. Weber P; Becker EW; Jenss H Dtsch Med Wochenschr; 1988 Nov; 113(46):1806-7. PubMed ID: 3191853 [TBL] [Abstract][Full Text] [Related]
11. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease]. Netzer P Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032 [TBL] [Abstract][Full Text] [Related]
12. IBD: which 5-ASA drug works where? Ferry GD J Pediatr Gastroenterol Nutr; 1993 May; 16(4):474-5. PubMed ID: 8315560 [No Abstract] [Full Text] [Related]
15. Second trial of mesalamine therapy in the treatment of active Crohn's disease. Singleton J Gastroenterology; 1994 Aug; 107(2):632-3. PubMed ID: 8039647 [No Abstract] [Full Text] [Related]
16. Maintaining remission of Crohn's disease. Novak E CMAJ; 1988 Jul; 139(1):14. PubMed ID: 3383034 [No Abstract] [Full Text] [Related]
17. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer? Tremaine WJ Gastroenterology; 1992 Aug; 103(2):694-6. PubMed ID: 1353043 [No Abstract] [Full Text] [Related]
18. Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease. Debongnie JC; Dekoninck X J Clin Gastroenterol; 1994 Dec; 19(4):348-9. PubMed ID: 7876525 [No Abstract] [Full Text] [Related]
19. [Mesalazine in Crohn disease]. Linnestad P Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3252. PubMed ID: 2256041 [No Abstract] [Full Text] [Related]
20. Mesalazine as maintenance treatment in Crohn's disease. Vos J; Lesterhuis W Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923 [No Abstract] [Full Text] [Related] [Next] [New Search]